Shahd S. Almohsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shahd S. Almohsen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Alaa A Salim
King Abdul Aziz Med City, Dept Pathol & Lab Med, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
1 shared publication- Ali Naraghi
University Health Network, Mount Sinai Hospital, Women’s College Hospital, University of Toronto
1 shared publication - Anthony Michael Griffin
Division of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada
1 shared publication - Elizabeth G. Demicco
Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
1 shared publication - Graham Ashburner
Department of Medical Imaging, Division of Musculoskeletal Imaging, University of Toronto, Toronto, Canada
1 shared publication - Haitham Arabi
Pathology and Laboratory Medicine Department, King Abdulaziz Medical City , Riyadh 11461 , Kingdom of Saudi Arabia
1 shared publication
Latest Publications
- 11 October 2025
- Published by Springer Nature in Skeletal Radiology
- Vol. 55 (2) , 425-438
Clinical and magnetic resonance imaging features of soft tissue extraskeletal myxoid chondrosarcoma: A retrospective observational cohort study
Objectives To review the MRI, histological, and clinical features of extraskeletal myxoid chondrosarcoma (EMC). Methods Retrospective review of pre-treatment MRIs in 44 patients with pathologically proven EMC. Patient demographics, tumor MR-imaging features, histology and gene rearrangements, clinical management, and follow-up were reviewed. MRI features assessed included lesion size, location, morphology, signal characteristics, and relation to adjacent structures. Correlative analysis was performed to assess associations between demographic, clinical, molecular, and MRI variables with metastatic disease. Results EMCs were predominantly located in the lower extremity (38/44, 86%) and deep-to-fascia (36/44, 82%). All lesions (44/44) demonstrated well-circumscribed margins. Mean maximal dimension was 8.8 cm (range 1.7–36 cm); 93% (41/44) of lesions were hyperintense on fat-suppressed T2-weighted/ STIR imaging. Post-contrast enhancement was “solid” (> 80% enhancement) in 18%, “mixed” (20–80% enhancement) in 53%, and “sparse” (< 20% enhancement) in 29%. Nodal metastases were detected on preoperative imaging in four patients (9%), and pulmonary metastases in three cases preoperatively, and five cases postoperatively (range 14–128 months). EWSR1::NR4A3 fusion rearrangements were documented in 25 tumors (57%), and non-EWSR1 NR4A3 fusions in six cases (14%). The only variable demonstrating a significant correlation with metastatic disease was “solid” pattern of lesional enhancement (p = 0.035). Conclusions EMC is most commonly a deep lesion of the extremities demonstrating hyperintense T2-weighted signal, internal septations, and variable patterns of enhancement on MRI. Nodal disease is relatively frequent, and prolonged surveillance is recommended as metastases may develop years after diagnosis. Although analysis is limited by small case numbers, a “solid” (> 80%) pattern of enhancement was significantly associated with metastatic disease.
- 11 October 2025
- Published by Springer Nature in Skeletal Radiology
- Vol. 55 (2) , 425-438
Clinical and magnetic resonance imaging features of soft tissue extraskeletal myxoid chondrosarcoma: A retrospective observational cohort study
Objectives To review the MRI, histological, and clinical features of extraskeletal myxoid chondrosarcoma (EMC). Methods Retrospective review of pre-treatment MRIs in 44 patients with pathologically proven EMC. Patient demographics, tumor MR-imaging features, histology and gene rearrangements, clinical management, and follow-up were reviewed. MRI features assessed included lesion size, location, morphology, signal characteristics, and relation to adjacent structures. Correlative analysis was performed to assess associations between demographic, clinical, molecular, and MRI variables with metastatic disease. Results EMCs were predominantly located in the lower extremity (38/44, 86%) and deep-to-fascia (36/44, 82%). All lesions (44/44) demonstrated well-circumscribed margins. Mean maximal dimension was 8.8 cm (range 1.7–36 cm); 93% (41/44) of lesions were hyperintense on fat-suppressed T2-weighted/ STIR imaging. Post-contrast enhancement was “solid” (> 80% enhancement) in 18%, “mixed” (20–80% enhancement) in 53%, and “sparse” (< 20% enhancement) in 29%. Nodal metastases were detected on preoperative imaging in four patients (9%), and pulmonary metastases in three cases preoperatively, and five cases postoperatively (range 14–128 months). EWSR1::NR4A3 fusion rearrangements were documented in 25 tumors (57%), and non-EWSR1 NR4A3 fusions in six cases (14%). The only variable demonstrating a significant correlation with metastatic disease was “solid” pattern of lesional enhancement (p = 0.035). Conclusions EMC is most commonly a deep lesion of the extremities demonstrating hyperintense T2-weighted signal, internal septations, and variable patterns of enhancement on MRI. Nodal disease is relatively frequent, and prolonged surveillance is recommended as metastases may develop years after diagnosis. Although analysis is limited by small case numbers, a “solid” (> 80%) pattern of enhancement was significantly associated with metastatic disease.
- Open Access
- 3 June 2021
- Published by Springer Nature in Cureus
- Vol. 13 (6)
Pelvic Radiation-Induced Sarcoma With Rhabdomyoblastic Differentiation Following Treatment of Cervical Cancer
Radiation-induced sarcomas (RIS) are a rare long-term complication of radiation therapy, with a reported incidence of 2.5-5.5%. They usually develop several years following exposure to radiotherapy. The most common reported subtypes are undifferentiated pleomorphic sarcoma, angiosarcoma, and leiomyosarcoma. Breast cancer is the most common primary malignancy preceding RIS, followed by uterine cervical carcinoma. Only a few cases of RIS with rhabdomyoblastic differentiation have been reported in the literature, usually following the treatment of retinoblastoma. Herein, we report a rare case of RIS with rhabdomyoblastic differentiation in the pelvic region developing 12 years after cervical cancer radiation therapy.
- 3 June 2021
- Published by Springer Nature in Cureus
- Vol. 13 (6)
Open AccessPelvic Radiation-Induced Sarcoma With Rhabdomyoblastic Differentiation Following Treatment of Cervical Cancer
Radiation-induced sarcomas (RIS) are a rare long-term complication of radiation therapy, with a reported incidence of 2.5-5.5%. They usually develop several years following exposure to radiotherapy. The most common reported subtypes are undifferentiated pleomorphic sarcoma, angiosarcoma, and leiomyosarcoma. Breast cancer is the most common primary malignancy preceding RIS, followed by uterine cervical carcinoma. Only a few cases of RIS with rhabdomyoblastic differentiation have been reported in the literature, usually following the treatment of retinoblastoma. Herein, we report a rare case of RIS with rhabdomyoblastic differentiation in the pelvic region developing 12 years after cervical cancer radiation therapy.
- Open Access
- 1 May 2016
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 37 (5) , 591
Attitudes and beliefs on organ donation among students in a university in Central Saudi Arabia
Saudi Medical Journal;SMJ;smj;saudi medical journal;saudi medical journals
- 1 May 2016
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 37 (5) , 591
Open AccessAttitudes and beliefs on organ donation among students in a university in Central Saudi Arabia
Saudi Medical Journal;SMJ;smj;saudi medical journal;saudi medical journals